ACCOLATE (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the ACCOLATE drug offered from AstraZeneca Pharmaceuticals LP. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Zafirlukast |
| SUBSTANCE NAME: | ZAFIRLUKAST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-10-01 |
| END MARKETING DATE: | 0000-00-00 |
ACCOLATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ACCOLATE from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 1996-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-0401_2b0262a7-3717-4db6-8be7-f419812dda5f |
| PRODUCT NDC: | 0310-0401 |
| APPLICATION NUMBER: | NDA020547 |
Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:
